Table: Zeria Pharm - 9-MTH group results

Zeria Pharmaceutical

05/02/2025 07:00

Feb 5 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2024        Dec 31, 2023     Mar 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             64.77               57.92            86.50    
                 (+11.8 pct)         (+12.0 pct)      (+14.2 pct) 
  Operating         10.25                9.49            12.00    
                 (+8.0 pct)          (+11.0 pct)      (+24.7 pct) 
  Recurring         10.66                9.44            12.00    
                 (+12.9 pct)         (+35.7 pct)      (+41.0 pct) 
  Net                8.23                8.42             9.00    
                 (-2.3 pct)          (+40.8 pct)      (+16.4 pct) 
  EPS            186.63 yen          191.09 yen       204.18 yen  
  Ann Div                             44.00 yen        46.00 yen  
  -Q2 div         23.00 yen           22.00 yen                   
  -Q4 div                             22.00 yen        23.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T